Rockefeller Financial Services’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,940
Closed -$245K 520
2017
Q3
$245K Sell
10,940
-826
-7% -$18.7K ﹤0.01% 318
2017
Q2
$285K Hold
11,766
0.01% 271
2017
Q1
$225K Buy
11,766
+7,637
+185% +$134K ﹤0.01% 301
2016
Q4
$81K Sell
4,129
-12,351
-75% -$224K ﹤0.01% 389
2016
Q3
$261K Hold
16,480
0.01% 291
2016
Q2
$233K Hold
16,480
﹤0.01% 313
2016
Q1
$277K Sell
16,480
-1,475
-8% -$26K 0.01% 298
2015
Q4
$403K Buy
17,955
+6,346
+55% +$131K 0.01% 275
2015
Q3
$254K Buy
11,609
+5,948
+105% +$149K 0.01% 310
2015
Q2
$139K Buy
+5,661
New +$126K ﹤0.01% 343

Other funds holding ATRC

Rockefeller Financial Services's ATRC Position: Q4 2017 in Review

Rockefeller Financial Services sold out of AtriCure (ATRC) in Q4 2017, closing a stake of 10,940 shares — an estimated $245K sold.

Rockefeller Financial Services first reported a position in ATRC in Q2 2015 and held it in 10 quarters. The position peaked at $403K in Q4 2015. 109 funds tracked by Wall St. Rank hold ATRC as of Q4 2017.

  • Rockefeller Financial Services reported no remaining AtriCure position as of Q4 2017 after selling out during the quarter.
  • Rockefeller Financial Services sold 10,940 AtriCure shares in Q4 2017, an estimated $245K.
  • Rockefeller Financial Services first reported a position in AtriCure in Q2 2015 and held it in 10 quarters.
  • Rockefeller Financial Services's AtriCure position peaked at $403K in Q4 2015.
  • 109 funds tracked by Wall St. Rank held AtriCure as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.